We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

98 hedge funds and large institutions have $343M invested in Intersect ENT, Inc in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $286M → $343M (+$57.1M)

14% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 29

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 10098 (-2)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

100% less call options, than puts

Call options by funds: $4K | Put options by funds: $1.12M

Holders
98
Holders Change
-2
Holders Change %
-2%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
33
Reduced
29
Closed
16
Calls
$4K
Puts
$1.12M
Net Calls
-$1.12M
Net Calls Change
-$5M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
26
Bellevue Group
Switzerland
$3.25M
IHM
27
Iguana Healthcare Management
New York
$2.85M +$452K +30,000 +20%
SAM
28
Sectoral Asset Management
Quebec, Canada
$2.66M -$377K -25,000 -13%
CWG
29
C WorldWide Group
Denmark
$2.61M +$2.48M +165,000 New
Goldman Sachs
30
Goldman Sachs
New York
$2.52M +$2.18M +144,421 +994%
WRF
31
Waddell & Reed Financial
Kansas
$2.49M -$2.02M -133,800 -46%
Allianz Asset Management
32
Allianz Asset Management
Germany
$2.35M -$110K -7,295 -5%
Deutsche Bank
33
Deutsche Bank
Germany
$2.26M +$742K +49,247 +53%
Bank of America
34
Bank of America
North Carolina
$2.18M +$172K +11,421 +9%
JP Morgan Chase
35
JP Morgan Chase
New York
$1.96M -$345K -22,901 -16%
KCM
36
Kornitzer Capital Management
Kansas
$1.96M -$685K -45,500 -27%
MC
37
Menta Capital
California
$1.77M +$292K +19,374 +21%
MOACM
38
Mutual of America Capital Management
New York
$1.76M +$295K +19,600 +21%
PCM
39
Penn Capital Management
Pennsylvania
$1.75M -$4.53K -301 -0.3%
Charles Schwab
40
Charles Schwab
California
$1.7M +$626K +41,581 +63%
Wells Fargo
41
Wells Fargo
California
$1.65M +$113K +7,516 +8%
USAA
42
United Services Automobile Association
Texas
$1.65M -$906K -60,190 -37%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.57M +$92.7K +6,157 +7%
BIM
44
BlackRock Investment Management
Delaware
$1.56M -$2.7K -179 -0.2%
RJA
45
Raymond James & Associates
Florida
$1.4M -$482 -32 -0%
TAM
46
Tiverton Asset Management
Delaware
$1.19M +$1.13M +75,000 New
QI
47
QS Investors
New York
$1.08M
CS
48
Candriam SCA
Luxembourg
$1.06M +$1.01M +67,000 New
FG
49
Formula Growth
Quebec, Canada
$985K
TA
50
Teachers Advisors
New York
$944K +$120K +7,991 +15%

XENT Hedge Fund Activity: Q3 2016 in Review

98 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2016, worth a combined $343M — up 20% from $286M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of XENT and 14 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 33 added.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $8.14M. The largest seller was Granahan Investment Management, cutting an estimated $8.41M.

  • 98 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2016, down from 100 in Q2 2016.
  • Funds reported $343M of Intersect ENT, Inc stock for Q3 2016, up 20% quarter-over-quarter.
  • 14 funds opened new Intersect ENT, Inc positions in Q3 2016 and 16 closed out, a net change of -2 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2016 was OppenheimerFunds, an estimated $8.14M added.
  • The largest Intersect ENT, Inc seller in Q3 2016 was Granahan Investment Management, an estimated $8.41M sold.

Based on aggregated 13F filings for Q3 2016.